Central sleep apnea treatment in patients with heart failure with reduced ejection fraction: a network meta-analysis
- PMID: 34698980
- DOI: 10.1007/s11325-021-02512-y
Central sleep apnea treatment in patients with heart failure with reduced ejection fraction: a network meta-analysis
Abstract
Purpose: Adaptive servo-ventilation (ASV) is contraindicated for the treatment of central sleep apnea (CSA) in patients with heart failure with reduced ejection fraction (HFrEF), limiting treatment options. Though continuous positive airway pressure (CPAP), bi-level PAP with back-up rate (BPAP-BUR), and transvenous phrenic nerve stimulation (TPNS) are alternatives, not much is known about their comparative efficacies, which formed the basis of conducting this network meta-analysis. We sought to analyze their comparative effectiveness in reducing apnea hypopnea index (AHI). Additionally, we also studied their comparative effectiveness on subjective daytime sleepiness as assessed by Epworth sleepiness score (ESS).
Methods: Randomized controlled trials (RCTs) from PubMed were analyzed in a network meta-analysis and relative superiority was computed based on P-score ranking and Hasse diagrams.
Results: Network meta-analysis based on 8 RCTs showed that when compared to guideline-directed medical therapy (GDMT-used as a common comparator across trials), reduction in AHI by ASV (- 26.05 [- 38.80; - 13.31]), TPNS (- 24.90 [- 42.88; - 6.92]), BPAP-BUR (- 20.36 [- 36.47; - 4.25]), and CPAP (- 16.01 [- 25.42; - 6.60]) were statistically significant but not between the interventions. Based on 6 RCTs of all the interventions, only TPNS showed a statistically significant decrease in ESS (- 3.70 (- 5.58; - 1.82)) when compared to GDMT, while also showing significant differences when compared with ASV (- 3.20 (- 5.86; - 0.54)), BPAP-BUR (- 4.00 (- 7.33; - 0.68)), and CPAP (- 4.45 (- 7.75; - 1.14)). Ranking of treatments based on Hasse diagram, accounting for both AHI and ESS as outcomes for relative hierarchy showed relative superiority of both ASV and TPNS over BPAP-BUR and CPAP.
Conclusions: Results indicated relative superiority of TPNS and ASV to BPAP-BUR and CPAP in their effects on AHI and ESS.
Keywords: Adaptive servo-ventilator; Apnea–hypopnea index; Bi-level positive airway pressure; Continuous positive airway pressure; Epworth sleepiness scale; Heart failure.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
Similar articles
-
Meta-Analysis Comparing Outcomes of Therapies for Patients With Central Sleep Apnea and Heart Failure With Reduced Ejection Fraction.Am J Cardiol. 2020 Jul 15;127:73-83. doi: 10.1016/j.amjcard.2020.04.011. Epub 2020 Apr 24. Am J Cardiol. 2020. PMID: 32430162 Review.
-
[Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome].Zhonghua Jie He He Hu Xi Za Zhi. 2008 Sep;31(9):664-9. Zhonghua Jie He He Hu Xi Za Zhi. 2008. PMID: 19080566 Clinical Trial. Chinese.
-
A network meta-analysis of different positive airway pressure interventions in obesity hypoventilation syndrome.J Sleep Res. 2021 Jun;30(3):e13158. doi: 10.1111/jsr.13158. Epub 2020 Aug 12. J Sleep Res. 2021. PMID: 32789956
-
Effect of Treatment of Central Sleep Apnea/Cheyne-Stokes Respiration on Left Ventricular Ejection Fraction in Heart Failure: A Network Meta-Analysis.J Clin Sleep Med. 2019 Dec 15;15(12):1817-1825. doi: 10.5664/jcsm.8092. Epub 2019 Oct 30. J Clin Sleep Med. 2019. PMID: 31855167 Free PMC article.
-
Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis.Cureus. 2022 Jan 31;14(1):e21759. doi: 10.7759/cureus.21759. eCollection 2022 Jan. Cureus. 2022. PMID: 35251830 Free PMC article. Review.
Cited by
-
Novel Device Therapies for Heart Failure.J Cardiovasc Dev Dis. 2023 Apr 11;10(4):165. doi: 10.3390/jcdd10040165. J Cardiovasc Dev Dis. 2023. PMID: 37103044 Free PMC article.
-
Central sleep apnoea: not just one phenotype.Eur Respir Rev. 2024 Mar 27;33(171):230141. doi: 10.1183/16000617.0141-2023. Print 2024 Jan 31. Eur Respir Rev. 2024. PMID: 38537948 Free PMC article. Review.
References
-
- Costanzo MR, Khayat R, Ponikowski P, Augostini R, Stellbrink C, Mianulli M, Abraham WT (2015) Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol 65(1):72–84. https://doi.org/10.1016/j.jacc.2014.10.025 - DOI - PubMed - PMC
-
- Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257. https://doi.org/10.1016/j.ejheart.2006.08.003 - DOI - PubMed
-
- Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA (2002) Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am J Respir Crit Care Med 165(9):1245–1250. https://doi.org/10.1164/rccm.200110-022OC - DOI - PubMed
-
- Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM (2001) Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 22(13):1136–1143. https://doi.org/10.1053/euhj.2000.2407 - DOI - PubMed
-
- Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J (2009) The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 54(19):1747–1762. https://doi.org/10.1016/j.jacc.2009.05.015 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials